For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...
Pillar Biosciences, Inc., the leader in Decision Medicine™, has announced the launch of oncoReveal® Lymphoid, a ...
Geneseeq Technology Inc., a global precision oncology company, today announced its PanTRKare™NTRK1/NTRK2/NTRK3 Gene Fusion Detection Kit has received ...
Revvity, Inc., today announced the launch of new highly-characterized somatic cancer reference standards developed in collaboration with the Medical Device Innovation Consortium (MDIC) and the ...
LabGenomics announced on the 24th that it has completed the development of cancer diagnostic NGS (Next-Generation Sequencing) services and will introduce them to its 100% US subsidiary, CliaLab QDx ...
Dublin, Dec. 31, 2021 (GLOBE NEWSWIRE) -- The "India Oncology NGS Market Size, Share & Trends Analysis Report by End-use (Clinical Research, Hospitals & Clinics), Technology, Application, Product & ...
IDT and Beckman Coulter Life Sciences' collaboration marks a significant step forward in enabling labs to streamline oncology research workflows with enhanced precision, scalability, and ...
Founded by Dr. Thomas Crisman, Genome Based Diagnostics has focused on developing accessible and reliable testing solutions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback